Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout (2019)

First Author: Hill-McManus D
Attributed to:  North West HTMR funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 30993686

Publication URI:

Type: Journal Article/Review

Parent Publication: Clinical Pharmacology & Therapeutics

Issue: 3